CRST Europe · February 2016
From Workbench to Clinical Proof of Concept: Mirricon
Relevant to founders, R&D leaders and investors deciding which milestone should come next.
Read at publisher ↗FOR INVESTORS
Assess the evidence before your next ophthalmic investment.
A strong scientific result is only part of an investment case. I help examine the clinical need, evidence gaps and adoption assumptions that could change your decision.
01
Clinical need
Who has the problem, how is it addressed today, and what improvement would justify switching?
02
Evidence
What do the studies demonstrate—and what remains an assumption? Examine design, follow-up, relevance and missing data.
03
Adoption
What could prevent repeat use? Look at training, workflow, patient experience and the practical economics of delivery.
04
Next milestone
Which unanswered question could change the investment decision, and what evidence would resolve it?
Send a non-confidential technology overview, the evidence available and the decision you are considering.
The discussion focuses on what is established, what remains uncertain and which next milestone matters most.
Scope and availability are agreed for each engagement.
The Ophthalmologist · December 2014
Translational Research: Innovate Horizontally
Relevant to development teams assessing whether an existing technology can answer an unmet clinical need.
Read at publisher ↗